<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05070949</url>
  </required_header>
  <id_info>
    <org_study_id>2933</org_study_id>
    <nct_id>NCT05070949</nct_id>
  </id_info>
  <brief_title>Self-compassion to Reduce Diabetes Distress in Persons With Type 1 Diabetes</brief_title>
  <official_title>Self-compassion to Reduce Diabetes Distress in Persons With Type 1 Diabetes</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Mahidol University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Chulalongkorn University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Mahidol University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study explored the effects of self-compassion intervention on diabetes distress and&#xD;
      self-compassion.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This study tests the effects of a 12-week mindful self-compassion (MSC) program in people&#xD;
      with type 1 diabetes. Eighty participants will be randomized to the MSC program or be in a&#xD;
      wait-list control group. Measures of primary outcome are self-compassion and diabetes-&#xD;
      distress. Secondary outcomes are hemoglobin A1C, diabetes self-efficacy, stress and&#xD;
      depression symptoms, and sleep quality. Outcomes will be measured at baseline, 12 weeks (end&#xD;
      of the program) and 24 weeks (post program).&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">November 1, 2021</start_date>
  <completion_date type="Anticipated">September 1, 2024</completion_date>
  <primary_completion_date type="Anticipated">April 1, 2024</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Diabetes distress</measure>
    <time_frame>baseline to 24 weeks</time_frame>
    <description>Diabetes distress will be evaluated by a questionnaire. Each item is rated on a 6-point Likert scale from 1 (no problem) to 6 (serious problems).&#xD;
Scores range from 17 to 102, which the higher scores indicate the higher diabetes distress levels (A worse outcome).</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Self-compassion</measure>
    <time_frame>baseline to 24 weeks</time_frame>
    <description>Self-compassion will be evaluated by a questionnaire. Each item is rated on a 5-point Likert scale from 1 (strongly disagree) to 5 (strongly agree).&#xD;
Scores range from 26 to 130, which the higher scores indicate the higher self-compassion levels (A better outcome). This outcome is reported in the mean difference of self-compassion score between two groups.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Diabetes Self-efficacy</measure>
    <time_frame>baseline to 24 weeks</time_frame>
    <description>Diabetes self-efficacy will be measured by questionnaire. Each item is rated on a 5-point Likert scale from 1 (strongly disagree) to 5 (strongly agree).&#xD;
Scores range from 19 to 95, which the higher scores indicate the higher self-efficacy levels (A better outcome).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Hemoglobin A1C</measure>
    <time_frame>baseline and 12 weeks</time_frame>
    <description>HbA1c will be obtained by blood test.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Sleep quality</measure>
    <time_frame>baseline to 24 weeks</time_frame>
    <description>Sleep quality will be measured by a questionnaire. Each item is rated on a 4-point Likert scale from 0 (very good) to 3 (very bad).&#xD;
Scores range from 0 to 21, which the higher scores indicate poor sleep quality (A worse outcome).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Stress and depressive symptoms</measure>
    <time_frame>baseline to 24 weeks</time_frame>
    <description>stress and depressive symptoms will be measured by a questionnaire. Each item is rated on a 5-point Likert scale from 0 (never) to 4 (very often). Scores range from 0 to 40, which the higher scores indicate higher stress and depression (A worse outcome). This outcome is reported in the mean difference of stress and depression score between two groups.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">80</enrollment>
  <condition>Type 1 Diabetes</condition>
  <arm_group>
    <arm_group_label>Mindful Self-Compassion</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Participants will meet every 2 weeks via zoom application or equivalent online meeting platforms, for 12 weeks. The sessions will be led by a clinical psychologist. The curriculum will follow mindful compassion program by Neff KD</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Wait List Control</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Wait list control group will not participate in the MSC program during the first 12 weeks of the protocol but will be given an opportunity to participate after 12 weeks, using the same curriculum.</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Mindful Self-Compassion</intervention_name>
    <description>Bi-weekly meeting will involve six lessons: What is Self-Compassion , Practicing Self-Compassion, Discovering your Compassionate Voice, Self-Compassion and Resilience , Self-Compassion and Burnout and Making it Count</description>
    <arm_group_label>Mindful Self-Compassion</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  type 1 diabetes, age 18-30&#xD;
&#xD;
          -  own computer or tablet with access to internet for meetings&#xD;
&#xD;
          -  willingness to complete all 6 sessions&#xD;
&#xD;
        Exclusion criteria:&#xD;
&#xD;
          -  history of self-harm or suicide attempt in the pat one year&#xD;
&#xD;
          -  severe diabetic complications such as dialysis or blindness&#xD;
&#xD;
          -  unstable depression, requiring ongoing medication adjustment within the last 3 months&#xD;
&#xD;
          -  A1C &gt; 11%&#xD;
&#xD;
          -  Severe hypoglycemia requiring emergency room visit or hospitalization in the past 6&#xD;
             months&#xD;
&#xD;
          -  History of Diabetic Ketoacidosis requiring hospitalization in the past 3 months&#xD;
&#xD;
          -  pregnant or intend to get pregnant during the study timeframe&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>30 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Faculty of Medicine Ramathibodi Hospital</name>
      <address>
        <city>Bangkok</city>
        <state>Ratchatewi</state>
        <zip>10400</zip>
        <country>Thailand</country>
      </address>
    </facility>
    <contact>
      <last_name>Ratanaporn Jerawatana, APN</last_name>
      <phone>66635194653</phone>
      <email>ratanaporn.jer@gmail.com</email>
    </contact>
    <investigator>
      <last_name>Sirimon Reutrakul, M.D</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Chorthip Nartsupha Phattanasri, M.D</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Sira Korpaisarn, M.D</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Porntip Tachanivate, Msc</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Chatvara Areevut, Msc</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Nampeth Saibuathong, Msc</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Amornrat Hathaidechadusadee, Msc</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Jandanee Sakmanarit, Msc</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Chollada Deeampai, Bs</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Sunee Saetung, Msc</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Benjamin Weinstein, PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Faculty of Medicine Chulalongkorn University</name>
      <address>
        <city>Bangkok</city>
        <zip>10330</zip>
        <country>Thailand</country>
      </address>
    </facility>
    <contact>
      <last_name>Taninee Sahakitrungruang, MD</last_name>
      <phone>66816468083</phone>
      <email>taninee.p@chula.ac.th</email>
    </contact>
    <investigator>
      <last_name>Nitchakarn Laichuthai, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Nattakarn Numsriskulrat, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Thailand</country>
  </location_countries>
  <reference>
    <citation>Fisher L, Hessler DM, Polonsky WH, Mullan J. When is diabetes distress clinically meaningful?: establishing cut points for the Diabetes Distress Scale. Diabetes Care. 2012 Feb;35(2):259-64. doi: 10.2337/dc11-1572. Epub 2012 Jan 6.</citation>
    <PMID>22228744</PMID>
  </reference>
  <reference>
    <citation>Aikens JE. Prospective associations between emotional distress and poor outcomes in type 2 diabetes. Diabetes Care. 2012 Dec;35(12):2472-8. doi: 10.2337/dc12-0181. Epub 2012 Oct 1.</citation>
    <PMID>23033244</PMID>
  </reference>
  <reference>
    <citation>Fisher L, Glasgow RE, Strycker LA. The relationship between diabetes distress and clinical depression with glycemic control among patients with type 2 diabetes. Diabetes Care. 2010 May;33(5):1034-6. doi: 10.2337/dc09-2175. Epub 2010 Feb 11.</citation>
    <PMID>20150291</PMID>
  </reference>
  <reference>
    <citation>Fisher L, Hessler D, Polonsky W, Strycker L, Masharani U, Peters A. Diabetes distress in adults with type 1 diabetes: Prevalence, incidence and change over time. J Diabetes Complications. 2016 Aug;30(6):1123-8. doi: 10.1016/j.jdiacomp.2016.03.032. Epub 2016 Apr 4.</citation>
    <PMID>27118163</PMID>
  </reference>
  <reference>
    <citation>Nicolucci A, Kovacs Burns K, Holt RI, Comaschi M, Hermanns N, Ishii H, Kokoszka A, Pouwer F, Skovlund SE, Stuckey H, Tarkun I, Vallis M, Wens J, Peyrot M; DAWN2 Study Group. Diabetes Attitudes, Wishes and Needs second study (DAWN2™): cross-national benchmarking of diabetes-related psychosocial outcomes for people with diabetes. Diabet Med. 2013 Jul;30(7):767-77. doi: 10.1111/dme.12245. Erratum in: Diabet Med. 2013 Oct;30(10):1266.</citation>
    <PMID>23711019</PMID>
  </reference>
  <reference>
    <citation>Friis AM, Johnson MH, Cutfield RG, Consedine NS. Kindness Matters: A Randomized Controlled Trial of a Mindful Self-Compassion Intervention Improves Depression, Distress, and HbA1c Among Patients With Diabetes. Diabetes Care. 2016 Nov;39(11):1963-1971. Epub 2016 Jun 22.</citation>
    <PMID>27335319</PMID>
  </reference>
  <reference>
    <citation>Neff KD, Germer CK. A pilot study and randomized controlled trial of the mindful self-compassion program. J Clin Psychol. 2013 Jan;69(1):28-44. doi: 10.1002/jclp.21923. Epub 2012 Oct 15.</citation>
    <PMID>23070875</PMID>
  </reference>
  <reference>
    <citation>Tunsuchart K, Lerttrakarnnon P, Srithanaviboonchai K, Likhitsathian S, Skulphan S. Type 2 Diabetes Mellitus Related Distress in Thailand. Int J Environ Res Public Health. 2020 Mar 30;17(7). pii: E2329. doi: 10.3390/ijerph17072329.</citation>
    <PMID>32235629</PMID>
  </reference>
  <reference>
    <citation>Lotrakul M, Sumrithe S, Saipanish R. Reliability and validity of the Thai version of the PHQ-9. BMC Psychiatry. 2008 Jun 20;8:46. doi: 10.1186/1471-244X-8-46.</citation>
    <PMID>18570645</PMID>
  </reference>
  <reference>
    <citation>Sitasuwan T, Bussaratid S, Ruttanaumpawan P, Chotinaiwattarakul W. Reliability and validity of the Thai version of the Pittsburgh Sleep Quality Index. J Med Assoc Thai. 2014 Mar;97 Suppl 3:S57-67.</citation>
    <PMID>24772581</PMID>
  </reference>
  <reference>
    <citation>Wongpakaran N, Wongpakaran T. The Thai version of the PSS-10: An Investigation of its psychometric properties. Biopsychosoc Med. 2010 Jun 12;4:6. doi: 10.1186/1751-0759-4-6.</citation>
    <PMID>20540784</PMID>
  </reference>
  <verification_date>October 2021</verification_date>
  <study_first_submitted>May 15, 2021</study_first_submitted>
  <study_first_submitted_qc>October 6, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">October 7, 2021</study_first_posted>
  <last_update_submitted>October 10, 2021</last_update_submitted>
  <last_update_submitted_qc>October 10, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">October 19, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Mahidol University</investigator_affiliation>
    <investigator_full_name>Ratanaporn Jerawatana</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <keyword>self-compassion</keyword>
  <keyword>diabetes distress</keyword>
  <keyword>sleep</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Diabetes Mellitus</mesh_term>
    <mesh_term>Diabetes Mellitus, Type 1</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

